HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Tachezy Selected Research

Activated-Leukocyte Cell Adhesion Molecule (Neurolin)

8/2016Prognostic Impact of Activated Leucocyte Cell Adhesion Molecule (ALCAM/CD166) in Infantile Neuroblastoma.
10/2014Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC).
6/2014Activated leukocyte cell adhesion molecule (CD166): an "inert" cancer stem cell marker for non-small cell lung cancer?
9/2012Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.
7/2012ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients.
1/2012Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.
1/2012ALCAM (CD166) expression and serum levels in pancreatic cancer.
12/2011Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer.
10/2011ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Tachezy Research Topics

Disease

19Neoplasms (Cancer)
04/2022 - 05/2011
9Adenocarcinoma
02/2022 - 08/2011
6Neoplasm Metastasis (Metastasis)
01/2020 - 10/2011
6Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 01/2012
4Esophageal Neoplasms (Esophageal Cancer)
10/2021 - 07/2012
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2019 - 01/2012
3Carcinogenesis
10/2021 - 08/2011
3Carcinoma (Carcinomatosis)
06/2021 - 09/2013
3Anastomotic Leak
06/2021 - 01/2020
2Neoplasms, Cystic, Mucinous, and Serous
01/2017 - 10/2010
2Chronic Pancreatitis
01/2017 - 01/2012
2Atherosclerosis
03/2008 - 07/2007
1Sepsis (Septicemia)
01/2020
1Neuroblastoma
08/2016
1Stomach Neoplasms (Stomach Cancer)
01/2016
1Inflammation (Inflammations)
01/2016
1Squamous Cell Carcinoma of Head and Neck
10/2014
1Colorectal Neoplasms (Colorectal Cancer)
09/2012
1Lung Diseases (Lung Disease)
01/2012
1Breast Neoplasms (Breast Cancer)
01/2012
1Prostatic Neoplasms (Prostate Cancer)
12/2011
1Primitive Neuroectodermal Tumors (PNET)
10/2011
1Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2011
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
05/2011
1Pancreatic Fistula (Pancreatic Fistulas)
05/2011
1Infarction (Infarctions)
11/2010

Drug/Important Bio-Agent (IBA)

9Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
08/2016 - 10/2011
6Proteins (Proteins, Gene)FDA Link
03/2020 - 12/2011
4Biomarkers (Surrogate Marker)IBA
10/2021 - 10/2011
3Cell Adhesion MoleculesIBA
09/2019 - 01/2014
2Immunoglobulins (Immunoglobulin)IBA
08/2016 - 12/2011
2Chemokine ReceptorsIBA
09/2013 - 08/2011
1Indicators and Reagents (Reagents)IBA
04/2022
11-Acylglycerophosphocholine O-Acyltransferase (1 Acylglycerophosphocholine O Acyltransferase)IBA
10/2021
1SelectinsIBA
06/2021
1Integrin alphaVIBA
06/2021
1Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
03/2020
1Interleukin-10 (Interleukin 10)IBA
01/2020
1Interleukin-17 (Interleukin 17)IBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1130-nm albumin-bound paclitaxelIBA
09/2016
1folfirinoxIBA
09/2016
1GemcitabineFDA Link
09/2016
1Irinotecan (Camptosar)FDA LinkGeneric
09/2016
1Leucovorin (Folinic Acid)FDA Link
09/2016
1Fluorouracil (Carac)FDA LinkGeneric
09/2016
1Oxaliplatin (Eloxatin)FDA LinkGeneric
09/2016
1TenascinIBA
04/2016
1Tumor Biomarkers (Tumor Markers)IBA
04/2016
1C-Reactive ProteinIBA
01/2016
1AlbuminsIBA
01/2016
1Polysaccharides (Glycans)IBA
12/2014
1Blood Group Antigens (Blood Groups)IBA
12/2014
1GlycoconjugatesIBA
12/2014
1Glycoproteins (Glycoprotein)IBA
12/2014
1Immunoglobulin M (IgM)IBA
12/2014
1ABO Blood-Group SystemIBA
12/2014
1Epithelial Cell Adhesion MoleculeIBA
09/2014
1Carcinoembryonic AntigenIBA
01/2014
1Biological ProductsIBA
01/2014
1Chemokine CXCL12IBA
09/2013
1CXCR4 Receptors (CXCR4 Receptor)IBA
09/2013
1Messenger RNA (mRNA)IBA
01/2012
1Complementary DNA (cDNA)IBA
01/2012
1MicroRNAs (MicroRNA)IBA
01/2012
1Prostate-Specific Antigen (Semenogelase)IBA
12/2011
1Membrane Proteins (Integral Membrane Proteins)IBA
10/2011
1Hormones (Hormone)IBA
10/2011
1ChemokinesIBA
08/2011
1Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
05/2011
1EndoglinIBA
10/2010
1CholesterolIBA
03/2008
1Apolipoproteins E (ApoE)IBA
03/2008
1Ezetimibe (Zetia)FDA Link
03/2008
1ApolipoproteinsIBA
03/2008
1maleimideIBA
07/2007
1trans-sodium crocetinate (crocetin)IBA
07/2007
1CarbocyaninesIBA
07/2007

Therapy/Procedure

9Therapeutics
02/2022 - 05/2011
2Esophagectomy
02/2022 - 06/2021
2Neoadjuvant Therapy
02/2022 - 06/2014
1Aftercare (After-Treatment)
06/2021
1Stents
06/2021
1Catheters
01/2020
1Drug Therapy (Chemotherapy)
09/2016
1Metastasectomy
01/2016
1Lymph Node Excision (Lymph Node Dissection)
01/2016
1Prostatectomy (Retropubic Prostatectomy)
12/2011
1Pancreatectomy
05/2011
1Conservative Treatment
11/2010